Pages that link to "Q33869789"
Jump to navigation
Jump to search
The following pages link to Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice (Q33869789):
Displaying 23 items.
- Mouse models of polyglutamine diseases: review and data table. Part I (Q26853025) (← links)
- Impulsivity is associated with uric acid: evidence from humans and mice (Q30559234) (← links)
- Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice (Q34135360) (← links)
- In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease (Q35116551) (← links)
- Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease (Q35782283) (← links)
- Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice (Q37696661) (← links)
- Protein oxidation in Huntington disease. (Q37999718) (← links)
- Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility (Q38121068) (← links)
- The role of dopamine in Huntington's disease (Q38223504) (← links)
- What Gene Mutations Affect Serotonin in Mice? (Q38434699) (← links)
- Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model (Q38861728) (← links)
- Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation (Q39041217) (← links)
- Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease. (Q39217739) (← links)
- Neuroendocrine Coordination of Mitochondrial Stress Signaling and Proteostasis. (Q39407786) (← links)
- Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease (Q40963865) (← links)
- Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease. (Q45292629) (← links)
- Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability. (Q46732854) (← links)
- Delayed thalamic astrocytosis and disrupted sleep-wake patterns in a preclinical model of traumatic brain injury (Q47755550) (← links)
- Disrupted striatal neuron inputs and outputs in Huntington's disease. (Q52690256) (← links)
- Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review (Q64968129) (← links)
- The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease (Q90593606) (← links)
- Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease (Q96228741) (← links)
- Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice (Q99638675) (← links)